Viewing nowCombinationTelmisartan and Amlodipine Tablets 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 201606378 · Approved 2016.10.31 · Insurance code 665002200
Treatment of essential hypertension not controlled with monotherapy
This medication helps patients with essential hypertension who are insufficiently controlled on either Amlodipine or Telmisartan alone. It effectively lowers blood pressure and contributes to the reduction of cardiovascular risks. Essential hypertension refers to a condition where blood pressure is consistently high without a specific cause, and management is important. This medication is used for additional blood pressure control in such cases, ultimately helping to manage blood pressure reliably and protect heart and vascular health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution during administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
This medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions. For example, those who are allergic to this medication, pregnant or breastfeeding women, patients with severe liver disease, aortic stenosis, severe hypotension, cardiogenic shock, or unstable heart failure after acute myocardial infarction. Additionally, patients with primary aldosteronism, heart valve disease, liver impairment, gastrointestinal disorders, renal artery hypertension, dialysis patients, and the elderly should use this medication with caution, particularly when combined with other antihypertensive agents. Common side effects when taking this medication include dizziness and peripheral edema; rare but severe adverse reactions, such as fainting, may occur, so patients should consult healthcare providers immediately if they notice unusual symptoms. During pregnancy, starting or continuing this medication is contraindicated, and it should be discontinued as soon as pregnancy is confirmed. Breastfeeding women should also avoid taking this medication. Since this medication lowers blood pressure, hypotension may occur during the initiation of treatment or when adjusting doses; if hypotension symptoms present, the patient should be placed in a supine position and receive intravenous fluids if necessary. Due to the risk of hyperkalemia, patients with impaired renal function or heart failure should regularly monitor potassium levels in their blood, and caution should be taken when taking potassium supplements or foods high in potassium. Patients with diabetes and cardiovascular disease may have an increased risk of myocardial infarction while using this medication; therefore, appropriate diagnosis and treatment are necessary. This medication may cause drowsiness or dizziness, so caution should be taken when driving or operating hazardous machinery. In the event of an overdose, hypotension, tachycardia, or in severe cases, shock may occur, requiring immediate emergency treatment and careful monitoring of blood pressure and heart function. This medication is not recommended for children, as safety and efficacy have not been sufficiently established. For the elderly, it is safe to start on a low dose and gradually increase the dose.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in an airtight container protected from light. Additionally, it is important to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and safety.
White or off-white rectangular tablet
30 tablets (10 tablets/Alu-Alu * 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.